2[1]Russo P, Malacarne D, Falugi C, Trombino S, O'Connor PM.RPR-115135, a farnesyltransferase inhibitor, increase 5-FUcytotoxicity in ten human colon cancer cell lines: Role of p53.Int J Cancer 2002; 100:266-75.
3[2]Mori H, Niwa K, Zheng Q, et al. Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res 2001; 480-481:201-7.
4[3]Ding X, Flatt PR, Permert J, Adrian TE. Pancreatic cancer cells selectively stimulate islet beta cells to secrete amylin. Gastroenterology 1998; 114:130-8.
5[4]Rylova SN, Amalifitano A, Persaud-Sawin DA, et al. The CLN3gene is a novel molecular target for cancer drug discovery. Cancer Res 2002; 62:80l-8.
6[5]Gao Z, Fields JZ, Boman BM. Tumor-specific expression of anti-mdrl ribozyme selectively restores chemosensitivity in multidrug-resistant colon- adenocarcinoma cells. Int J Cancer 1999;82:346-52.
7[6]Shiraki K, Tsuji N, Shioda T, Isselbacher KJ, Takahashi H. Expression of Fas ligand in liver metastases of human colonic adenocarcinoma. Proc Natl Acad Sci USA 1997; 94:6420-5
8[7]Mateyak MK, Obaya AJ, Sedivy JM. C-myc regulates cyclin DCdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol Cell Biol 1999; 19:4672-83
9[8]Nagai MA, Habr-Gama A, Oshima CT, Brentani MM. Association of genetic alterations of c-myc, c-fos, and c-Ha-ras protooncogenes in colorectal tumors. Frquency and clinical significance.Dis Colon Rectum 1992; 35:444-51.
10[9]van Es JH, Giles RH, Clevers HC. The many faces of the tumor suppressor gene APC. Exp Cell Res 2001; 264:126-34
